Shin Poong Pharm.Co.,Ltd. (019170.KS)
KRW 10370.0
(-5.04%)
KRW 10370.0
(-5.04%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 53.92 Billion KRW | 14.99% |
| 2022 | 46.89 Billion KRW | -1.7% |
| 2021 | 47.7 Billion KRW | -2.81% |
| 2020 | 49.08 Billion KRW | 0.13% |
| 2019 | 49.02 Billion KRW | 9.1% |
| 2018 | 44.93 Billion KRW | -4.24% |
| 2017 | 46.92 Billion KRW | 11.19% |
| 2016 | 42.2 Billion KRW | -7.09% |
| 2015 | 45.42 Billion KRW | 3.37% |
| 2014 | 43.94 Billion KRW | 1.1% |
| 2013 | 43.46 Billion KRW | -3.99% |
| 2012 | 45.27 Billion KRW | 11.17% |
| 2011 | 40.72 Billion KRW | 1.81% |
| 2010 | 40 Billion KRW | 20.84% |
| 2009 | 33.1 Billion KRW | 4.35% |
| 2008 | 31.72 Billion KRW | 10.21% |
| 2007 | 28.78 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 57.94 Billion KRW | 7.46% |
| 2024 Q2 | 53.77 Billion KRW | -7.2% |
| 2023 Q1 | 51.89 Billion KRW | 10.65% |
| 2023 Q3 | 51.8 Billion KRW | 1.46% |
| 2023 FY | 53.92 Billion KRW | 14.99% |
| 2023 Q2 | 51.05 Billion KRW | -1.6% |
| 2023 Q4 | 53.92 Billion KRW | 4.09% |
| 2022 Q2 | 52.96 Billion KRW | 4.78% |
| 2022 Q4 | 46.89 Billion KRW | -1.07% |
| 2022 FY | 46.89 Billion KRW | -1.7% |
| 2022 Q1 | 50.54 Billion KRW | 5.96% |
| 2022 Q3 | 47.4 Billion KRW | -10.5% |
| 2021 Q4 | 47.7 Billion KRW | 0.49% |
| 2021 Q1 | 51.84 Billion KRW | 5.62% |
| 2021 Q2 | 49.12 Billion KRW | -5.25% |
| 2021 FY | 47.7 Billion KRW | -2.81% |
| 2021 Q3 | 47.47 Billion KRW | -3.36% |
| 2020 Q3 | 54.66 Billion KRW | -0.48% |
| 2020 Q2 | 54.92 Billion KRW | 0.28% |
| 2020 Q1 | 54.77 Billion KRW | 11.72% |
| 2020 FY | 49.08 Billion KRW | 0.13% |
| 2020 Q4 | 49.08 Billion KRW | -10.2% |
| 2019 Q1 | 45.75 Billion KRW | 1.81% |
| 2019 FY | 49.02 Billion KRW | 9.1% |
| 2019 Q4 | 49.02 Billion KRW | 0.65% |
| 2019 Q3 | 48.7 Billion KRW | 5.69% |
| 2019 Q2 | 46.08 Billion KRW | 0.73% |
| 2018 Q2 | 45.82 Billion KRW | -6.23% |
| 2018 Q4 | 44.93 Billion KRW | -4.36% |
| 2018 Q3 | 46.98 Billion KRW | 2.53% |
| 2018 FY | 44.93 Billion KRW | -4.24% |
| 2018 Q1 | 48.87 Billion KRW | 4.14% |
| 2017 Q3 | 43.78 Billion KRW | 6.48% |
| 2017 Q1 | 41.92 Billion KRW | -0.66% |
| 2017 FY | 46.92 Billion KRW | 11.19% |
| 2017 Q4 | 46.92 Billion KRW | 7.18% |
| 2017 Q2 | 41.12 Billion KRW | -1.93% |
| 2016 FY | 42.2 Billion KRW | -7.09% |
| 2016 Q3 | 43.33 Billion KRW | 6.3% |
| 2016 Q4 | 42.2 Billion KRW | -2.61% |
| 2016 Q2 | 40.76 Billion KRW | -9.06% |
| 2016 Q1 | 44.83 Billion KRW | -1.32% |
| 2015 Q3 | 49.69 Billion KRW | 1.22% |
| 2015 Q1 | 44.69 Billion KRW | 1.7% |
| 2015 FY | 45.42 Billion KRW | 3.37% |
| 2015 Q4 | 45.42 Billion KRW | -8.59% |
| 2015 Q2 | 49.09 Billion KRW | 9.85% |
| 2014 FY | 43.94 Billion KRW | 1.1% |
| 2014 Q3 | 41.94 Billion KRW | -12.34% |
| 2014 Q4 | 43.94 Billion KRW | 4.76% |
| 2014 Q2 | 47.85 Billion KRW | 4.68% |
| 2014 Q1 | 45.71 Billion KRW | 5.17% |
| 2013 Q1 | 44.52 Billion KRW | -1.66% |
| 2013 Q4 | 43.46 Billion KRW | -5.52% |
| 2013 FY | 43.46 Billion KRW | -3.99% |
| 2013 Q2 | 46.26 Billion KRW | 3.9% |
| 2013 Q3 | 46 Billion KRW | -0.55% |
| 2012 Q1 | 43.75 Billion KRW | 0.0% |
| 2012 Q4 | 45.27 Billion KRW | 0.0% |
| 2012 FY | 45.27 Billion KRW | 11.17% |
| 2011 Q2 | 42.58 Billion KRW | 6.02% |
| 2011 FY | 40.72 Billion KRW | 1.81% |
| 2011 Q3 | 40.97 Billion KRW | -3.79% |
| 2011 Q1 | 40.16 Billion KRW | 0.0% |
| 2010 Q2 | 32.5 Billion KRW | 1.05% |
| 2010 FY | 40 Billion KRW | 20.84% |
| 2010 Q3 | 36.29 Billion KRW | 11.67% |
| 2010 Q1 | 32.16 Billion KRW | 0.0% |
| 2009 Q2 | 33.83 Billion KRW | 4.77% |
| 2009 FY | 33.1 Billion KRW | 4.35% |
| 2009 Q3 | 34.46 Billion KRW | 1.85% |
| 2009 Q1 | 32.29 Billion KRW | 0.0% |
| 2008 FY | 31.72 Billion KRW | 10.21% |
| 2008 Q2 | 27.53 Billion KRW | 5.53% |
| 2008 Q1 | 26.09 Billion KRW | 0.0% |
| 2008 Q3 | 29.64 Billion KRW | 7.66% |
| 2007 Q2 | 24.33 Billion KRW | -0.37% |
| 2007 Q3 | 25.34 Billion KRW | 4.17% |
| 2007 FY | 28.78 Billion KRW | 0.0% |
| 2007 Q1 | 24.42 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -22.131% |
| Dong-A Socio Holdings Co., Ltd. | 117.85 Billion KRW | 54.245% |
| Ildong Holdings Co., Ltd. | 91.16 Billion KRW | 40.852% |
| HANDOK Inc. | 94.46 Billion KRW | 42.917% |
| Kukje Pharma Co., Ltd. | 21.24 Billion KRW | -153.839% |
| Yuhan Corporation | 284.75 Billion KRW | 81.064% |
| Dong-A ST Co., Ltd. | 116.31 Billion KRW | 53.64% |
| SAMSUNG PHARM. Co., LTD. | 16.25 Billion KRW | -231.658% |
| Hanmi Pharm. Co., Ltd. | 288.81 Billion KRW | 81.329% |
| Hanall Biopharma Co.,Ltd | 32.38 Billion KRW | -66.511% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | 12.639% |
| Dong Sung Bio Pharm.Co.,Ltd. | 19.47 Billion KRW | -176.855% |
| MYUNGMOON Pharm co.,Ltd | 30.28 Billion KRW | -78.081% |
| Hana Pharm Co., Ltd. | 48.34 Billion KRW | -11.533% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -22.131% |
| Ilsung Pharmaceuticals Co., Ltd. | 31.24 Billion KRW | -72.605% |
| REYON Pharmaceutical Co., Ltd. | 35.17 Billion KRW | -53.294% |
| Aprogen pharmaceuticals,Inc. | 48.12 Billion KRW | -12.041% |
| JW Holdings Corporation | 147.58 Billion KRW | 63.464% |
| Ildong Pharmaceutical Co., Ltd. | 84.62 Billion KRW | 36.279% |
| Chong Kun Dang Pharmaceutical Corp. | 261.43 Billion KRW | 79.374% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 49.173% |
| Hyundai Pharmaceutical Co., Ltd. | 26.99 Billion KRW | -99.731% |
| Samil Pharmaceutical Co.,Ltd | 32.51 Billion KRW | -65.86% |
| Jeil Pharmaceutical Co.,Ltd | 109.76 Billion KRW | 50.875% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -22.131% |
| Kwang Dong Pharmaceutical Co., Ltd. | 188.64 Billion KRW | 71.415% |
| Daewoong pharmaceutical Co.,Ltd | 241.54 Billion KRW | 77.676% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 49.173% |
| Yuhan Corporation | 284.75 Billion KRW | 81.064% |
| Jeil Pharma Holdings Inc | 125.28 Billion KRW | 56.958% |
| Yungjin Pharm. Co., Ltd. | 61.98 Billion KRW | 13.008% |
| Suheung Co., Ltd. | 259.84 Billion KRW | 79.248% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 49.173% |
| Samjin Pharmaceuticals Co., Ltd. | 79.6 Billion KRW | 32.26% |
| Korea United Pharm Inc. | 49.14 Billion KRW | -9.729% |
| CKD Bio Corp. | 69.08 Billion KRW | 21.943% |
| Daewon Pharmaceutical Co., Ltd. | 105.07 Billion KRW | 48.683% |
| Dongwha Pharm.Co.,Ltd | 70.69 Billion KRW | 23.726% |
| Whan In Pharm Co.,Ltd. | 54.05 Billion KRW | 0.249% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | 0.0% |
| Chong Kun Dang Holdings Corp. | 194.76 Billion KRW | 72.314% |
| Boryung Corporation | 189.8 Billion KRW | 71.59% |
| Bukwang Pharmaceutical Co., Ltd. | 56.83 Billion KRW | 5.118% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | 12.639% |
| JW Lifescience Corporation | 23.39 Billion KRW | -130.455% |